Work

Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depression

Year: 2007

Type: review

Source: International Clinical Psychopharmacology

DOI: 10.1097/yic.0b013e32821c6189

Authors: Richard C. Shelton, Anne C. Andorn, Craig H. Mallinckrodt, Madelaine M. Wohlreich, Joel Raskin, John G. Watkin, Michael J. Detke

Institutions: Vanderbilt University, Eli Lilly (United States)

Language: English

Topic: Treatment of Major Depression

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Pfizer Pharmaceuticals, Janssen Pharmaceuticals

OpenAlex ID: W1977851413

FWCI: 0.589

Cites: 51

Cited by: 36

Related to: 10